The “George Lopez Laboratory for Regenerative Cell Therapy” in the Department of Neurosurgery atMassachusetts General Hospital, a teaching affiliate of Harvard Medical School in Boston, Massachusetts, USAseeks motivated candidates from around the world to join our team at the postdoctoral research level.
In 2018, the Department of Neurosurgery Massachusetts General Hospital and the Laboratory of Molecular Neurobiology at McLean Hospital, both affiliated with Harvard Medical School, jointly completed the world’s first FDA-approved, autologous hiPSC-differentiated dopamine precursor cell implantation for the treatment of Parkinson’s disease (N Engl J Med. 2020; 382:20 1926-1932). The patient receiving treatment was Mr. George Lopez. To honor his contribution, in 2023 the “George Lopez Laboratory for Regenerative Cell Therapy” will open in the Department of Neurosurgery at MGH, aiming to support clinical trials of Parkinson’s disease cell therapy and to develop a new generation of methods to produce and implement novel cell therapies. The laboratory will also focus on research into the disease mechanisms of Parkinson’s disease as a basis for developing new therapies, with an emphasis on transformative translational application to Parkinson’s disease and other neurodegenerative diseases. This new laboratory consists of two parts: a GMP center to produce clinical-grade cells for human clinical trials, and a neurobiology laboratory for preclinical research. The laboratory is supported by a first-class team, adequate funding, advanced technology and a full suite of research equipment.
The role of clinical PI at the “George Lopez Laboratory for Regenerative Cell Therapy” is staffed by Jeffrey Schweitzer, MD, PhD, with support and collaboration by Bob S Carter, MD, PhD, Chief of Neurosurgery, and Todd Herrington, MD, PhD, principal movement disorder neurologist at MGH. We are actively building our team and are now recruiting for 4 postdoctoral fellows.
Candidate qualifications include:
1. PhD or MD degree in a relevant field such as neuroscience, stem cell biology, gene editing, immunology, etc.; grounding in clinical medicine or other biological or medical backgrounds
2. Experience in stem cell culture and neuron differentiation is highly valued.
3. Experience in neurodegenerative disease animal model, neural circuit, optogenetics, chemical genetics, electrophysiology, is highly valued.
4. Experience in gene editing, molecular biology is highly valued.
5. Experience in immunology is highly valued.
6. Teamwork spirit and communication skills
Please send CV to Dr. Jeffrey Schweitzer firstname.lastname@example.org
Massachusetts General Hospital is an affirmative action/equal opportunity employer and encourages applications from women and underrepresented minorities.